• Nenhum resultado encontrado

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

N/A
N/A
Protected

Academic year: 2017

Share "BRCA1: a novel prognostic factor in resected non-small-cell lung cancer."

Copied!
7
0
0

Texto

Loading

Imagem

Table 1. Nine genes examined in this study
Table 3. Correlation between expression levels of the nine genes examined
Figure 1. Event-free (A,B) and median (C,D) survival according to expression of TRX (A,C) and BRCA1 (B,D).

Referências

Documentos relacionados

These findings may explain why patients in our study whose tumors expressed NY-ESO-1 had significantly improved responses to neoadjuvant chemotherapy and yet no survival benefit

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung

(2015) Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with

social assistance. The protection of jobs within some enterprises, cooperatives, forms of economical associations, constitute an efficient social policy, totally different from

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small- cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03..

CONCLUSION: Serum albumin levels appear to be a significant independent prognostic factor for tumor recurrence in patients with stage I non-small cell lung cancer who have

Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de

In a previous study of cases of stage I non-small cell lung cancer (NSCLC), we also reported significant gender-related differences in long-term survival, with better rates